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regulação da termogênese gerada pelas vias de oxidação biológica
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ABSTRACT
Objective: We sought to identify glycolysis, glycogenolysis, lipolysis, Krebs cycle, respiratory 
chain, and oxidative phosphorylation enzymes simultaneously regulated by T3 and cAMP. 
Materials and methods: We performed in silico analysis of 56 promoters to search for cis-cAMP 
(CREB) and cis-thyroid (TRE) response elements, considering UCP1, SERCA2 and glyceraldehyde 
3-phosphate dehydrogenase as reference. Only regulatory regions with prior in vitro validation 
were selected. Results: 29/56 enzymes presented potential TREs in their regulatory sequence, 
and some scored over 0.80 (better predictive value 1): citrate synthase, phosphoglucose 
isomerase, succinate dehydrogenases A/C, UCP3, UCP2, UCP4, UCP5, phosphoglycerate mutase, 
glyceraldehyde 3-P dehydrogenase, glucokinase, malate dehydrogenase, acyl-CoA transferase 
(thiolase), cytochrome a3, and lactate dehydrogenase. Moreover, some enzymes have not yet 
been described in the literature as genomically regulated by T3. Conclusion: Our results point to 
other enzymes which may possibly be regulated by T3 and CREB, and speculate their joint roles 
in contributing to the optimal thermogenic acclimation. Arq Bras Endocrinol Metab. 2010;54(4):381-9
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ReSumo
Objetivo: Identificar enzimas das vias da glicólise, glicogenólise, lipólise, ciclo de Krebs, cadeia 
respiratória e fosforilação oxidativa possivelmente reguladas por T3 e cAMP. Materiais e méto-
dos: Analisamos 56 genes metabólicos in silico mediante a identificação dos elementos cis de 
regulação gênica responsivos ao T3 e cAMP (TREs, thyroid response elements e CREs, cAMP 
response elements), utilizando como referência o promotor da UCP1, SERCA2 e gliceraldeído 
3-fosfato desidrogenase. Selecionamos somente os promotores com estudo funcional prévio 
in vitro. Resultados: 29/56 enzimas apresentaram TREs em suas regiões regulatórias, parte com 
escore ≥ 0,80 (melhor valor preditivo 1): citrato sintase, fosfoglucose isomerase, succinato de-
sidrogenase A/C, UCP3, UCP2, UCP4, UCP5, fosfoglicerato mutase, gliceraldeído 3-P desidro-
genase, glucoquinase, malato desidrogenase, acil-CoA transferase (tiolase), citocromo a3, e 
lactato desidrogenase; parte desconhecida como regulada por T3. Conclusão: Os resultados do 
presente estudo apontam para novos genes regulados por T3 e cAMP e, por conseguinte, sua 
contribuição na regulação da termogênese. Arq Bras Endocrinol Metab. 2010;54(4):381-9
Descritores
Termogênese; T3R; CREB; regulação gênica; oxidação biológica 
InTRoDuCTIon
Body heat is a by-product of the transformation of chemical energy slowly released during food oxida-
tion. This apparent thermodynamic inefficiency keeps 
our body warm and optimizes the functioning of cells 
and systems. It is widely known that T3 is one of the key 
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T3 and cAMP regulatory role on thermometabolic genes
mediators of thermogenesis (1,2), especially through the 
control of transcriptional uncoupling proteins (UCPs) 
together with the partner cAMP-CREB, cyclic AMP re-
sponse element binding protein (1). In fact, UCPs opti-
mize the inefficiency of mitochondrial thermogenesis by 
shifting the gradient of protons from the ATP synthesis 
to generate heat (3), as the consequence of proton leak 
amplification. Despite of the recognized role of T3 in 
generating heat through UCP canonical thermogenic 
path (1,4,5), little is known about its transcriptional 
regulation in other metabolic oxidative enzymes. Much 
less is clear about T3R-CREB transcriptional regulation 
partnership in orchestrating the fuel oxidation pathways. 
Besides the accumulated evidence on T3R-CREB/
UCP thermogenic path (6), we should also consider 
adding the role of 3,5-diiodo-l-thyronine (T2) and the 
substrate, or futile cycling contributions to heat gene-
ration. In fact, it has been demonstrated that interplay 
between opposite metabolic routes such as glucose and 
glucose-6-phosphate and between fructose-6-phospha-
te and fructose-1,6-diphosphate occurs in man and is 
directly affected by T3, these substrate cycles contribu-
tion may represent a mechanism by which thyroid hor-
mone alters the sensitivity of certain reactions to me-
tabolic signals (7). Moreover, not only T3 but also T2 
enhances skeletal muscle mitochondrial thermogenesis 
by activating pathways involved in the dissipation of the 
proton-motive force (ATP generation) towards proton 
leak (heat), the effect being dependent on the presence 
of free fatty acids inside mitochondria (8). It may also 
be worth considering further comprehensive overviews 
on regulation of thermogenesis (1,9,10).
Why search for cis-elements in a set of regulatory 
genomic sequences? In the last decade a great amount 
of differentially expressed genes was made available by 
the widespread use of gene expression profiling, es-
pecially from microarray and SAGE analysis, without 
scrutinizing information about their transcriptional re-
gulation. In fact, these methods only take into account 
arrays created from cDNA sequences of pooled genes, 
and most of the transcriptional regulatory signals; ho-
wever, they are more likely to be in the promoter and 
enhancer/silencer regions.
Although it has been an arduous task delineating the 
regulatory region of a gene due to the difficulty in esta-
blishing the start and the end of its sequence, promoter 
sequences corresponding to selected cDNAs can be tra-
ced either by exon-mapping or discovered by in silico 
promoter prediction tools from whole genome sequen-
ces available on public databases (11-13), making it 
more straightforward. The lack of reliable definition of 
the promoter size has been overcome with new softwa-
re, but variability in the limits of regulatory regions still 
remains. Some programs in bioinformatics, for instance, 
also perform comparative promoter analysis among co-
expressed genes, and then identify common transcrip-
tion regulatory signals (14-16). These smart web-based 
tools can be applied to help narrow down an enormous 
amount of expressed genes provided by selecting cano-
nical transcription factors as filters, in addition to sor-
ting them by specific tissues or pathways. 
One of the most important transcriptional factors 
related to thermogenesis is CREB, which is constituti-
vely expressed in the cell. In fact, CREB activity is gre-
atly increased after phosphorylation by cAMP, which 
works as a cell sensor of a variety of stimuli, including 
those downstream of adenilate cyclase activation in the 
cell membrane (17,18). In addition, the TSH receptor 
is also mainly coupled to the cAMP cascade, in which 
the cAMP pathway exerts a dual function as it regu-
lates both thyroid hormone production and prolifera-
tion of thyroid epithelial cells (19). Interestingly, we 
have found that several thermometabolic steps can be 
simultaneously regulated at the transcriptional level by 
cAMP-CREB and T3/T3R (20-23), in which we pos-
tulate whether both factors do really have an intimate 
transcriptional crosstalk in generating heat. 
mATeRIAlS AnD meThoDS
We sought to identify enzymes involved in glycolysis, 
glycogenolysis, lipid ß-oxidation, Krebs cycle, respi-
ratory chain, and oxidative phosphorylation possibly 
regulated by T3 and cAMP. We performed in silico 
analysis of 56 promoters related to all enzymes invol-
ved in the above-mentioned metabolic routes to search 
for cis-thyroid response elements (TRE) together with 
c-AMP response elements (CRE), initially using the 
GENOMATIX program (16), available to academic 
institutions through the website: http://www.geno-
matix.de/cgi-bi. The latter predicts the best regulatory 
sequence of a gene based on the degree of conservation 
between orthologs, classifying it in the gold, silver or 
bronze groups accordingly with the best evidence for 
experimentally verified 5’ complete transcript, with 5’ 
end confirmed by the software prediction only, and an-
notated transcript without confirmation for 5’ sequen-
ce completeness, respectively. 
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We have accepted the lowest cutoff threshold ob-
tained from the analysis of the UCP1, SERCA2 and 
glyceraldehyde 3-phosphate dehydrogenase regulatory 
regions as reference, since they have been classically de-
monstrated in the literature as the strongest T3-regu-
lated genes. Indeed, we have only selected regulatory 
regions with a prior in vitro validation of the promoter, 
according to evidence made available from the GENO-
MATIX program termed golden promoter.
Once selected, the promoters were followed with 
a narrowing second screening using three indepen-
dent programs PROMO (24), ALIBABA2 (25), and 
TESS (15), all publicly available through sites: http://
alggen.lsi.upc.es/cgi-bin/promo_v3/promo, http://
www.gene-regulation.com/pub/programs/alibaba2, 
and http://www.cbil.upenn.edu/cgi-bin/tess. TESS 
uses human CREB (T00163) or T3R-beta1 (T00851) 
as core position factor filters for TRANSFAC strings, 
accepting 10% of Maximum Allowable String Misma-
tch (tmm), a real number ≥ 0 of log-likelihood ratio 
score (ts-a), and the Minimum string length (tw) of 6. 
In fact, most of the available programs for predicting 
transcription factor binding sites use known sites col-
lected from TRANSFAC major matrix, which contains 
data on transcription factors, their experimentally-pro-
ven binding sites, and an array of regulated genes. Its 
broad compilation of binding sites allows the derivation 
of positional weight matrices, so it calculates a p-value 
for each prediction (26). 
These programs are able to specifically search for 
T3R-b cis-element binding sites among all the trans-
criptional factors on a matrix, grouped within either 
RXR or CREB family on query regulatory sequences. 
We have only selected the binding sites for RXRF and 
CREB that have scored over the defined threshold, as-
suming a statistically significant p-value < 0.01 (provi-
ded by the program).
ReSulTS
We were able to identify 29 promoters that presented 
TREs among all 56 transcriptionally-inspected meta-
bolic enzymes as summarized on table 1. The top 10 
enzyme promoters that scored over 0.80 (better pre-
dictive value 1) were: citrate synthase, phosphogluco-
se isomerase, succinate dehydrogenase A/C, UCP3, 
UCP2, UCP4, UCP5, phosphoglycerate mutase, 
glycerol 3-phosphate dehydrogenase, glucokinase, ma-
late dehydrogenase, acyl-CoA transferase (thiolase), 
cytochrome a3, and lactate dehydrogenase. To the best 
of our knowledge some pulled enzymes have not yet 
been described in the literature as possibly regulated by T3. 
Therefore, our results point to more enzymes geno-
mically regulated by T3, possibly broadening its role 
in the metabolic process of thermogenesis. See table 1 
for more details regarding enzyme metabolic pathway 
and cell localization, their NCBI gene identification, 
the size of the promoter used for studying, the Initial 
screening by GENOMATIX program when the score 
was set on p < 0.01, the second screening using a more 
specific filter for CRE and TRE by PROMO programs 
of bioinformatics.
DISCuSSIon
Our study extends the participation of T3 regulation 
to many metabolic enzymes, adding to the understan-
ding of fuel oxidation enzymatic steps for generating 
heat, as summarized on figure 1. We also demonstrate 
the usefulness of several in silico available resources in 
searching for potential promoters and for better fishing 
of transcriptional signals. By using these bioinforma-
tics resources we were able to not only filter for specific 
transcriptional family factors, but also to compare pro-
moters for common ones. Part of the usefulness of the 
work described here lies in the ability of rapid screening 
of gene expression driven by hormonal control. As a re-
sult, we observed marked overlapping signals between 
T3R and CREB (trans-elements) signals, in searching 
for their cis-elements (TRE and CRE). From a theore-
tical viewpoint, we speculate that these transcriptional 
factors play adjunct roles in orchestrating some oxidati-
ve enzymes in the same thermometabolic routes. 
Most enzymes regulated by T3R/CREB identified 
in our study are well known as key steps of fuel me-
tabolism. However, some of them have not yet been 
described in the literature as being regulated by T3, 
of which the following stand out: Phosphoglucose Iso-
merase (Figure 1.2/1.3), Succinate Dehydrogenase C 
and Succinate Dehydrogenase A (Figure 1.6), NDU-
FV3/V1/V2 Flavoprotein NADH Dehydrogenase 1 
and COX4I1 − Cytochrome a / a3 (Figure 1.7/1.8), 
Uncoupling Protein 5 (Figure 1.7/1.9), Phospho-
glucomutase (Figure 1.3), ACAT1 acetyl-Coenzyme 
A acetyltransferase 1 (Thiolase 1) and ACAT2 acetyl-
Coenzyme A acetyltransferase 2 (Thiolase 2) (Figure 
1.1/1.5). These verified enzymes are particularly dis-
cussed as follows.
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Table 1. In silico screening of TRE (RXRF/T3R-b) and CRE (CREB/cAMP) cis-regulatory elements of metabolic enzyme 
nº
metabolic pathway 
enzyme
Cell 
localization
nCBI  
gene ID
 Initial screening by GenomATIX software
Second screening – filtering for 
T3R-b cis specific sites
Promoter 
size (bp)
Total nº 
of CReB 
cis sites
CReB (cAmP) score,  
p < 0.01
Total nº 
of RXRF 
cis sites 
RXRF (T3R-b) score, 
p < 0.01
Total nº 
PRomo 
software
Total nº 
AlIBABA2 
software
Total nº 
TeSS 
software
Glycolysis
1 Hexokinase Cytosolic 3098 602 2 2sl - 0.919 / 0.915 3 2sl - 0.853 / 0.816 3 1 0
2 Glucokinase Cytosolic 2646 668 0  - 1 1sl - 0.859 2 1 0
3 Phosphoglucose 
Isomerase
Cytosolic 2821 601 4 3sl - 0.771 / 0.912 / 0.944 2 2sl - 0.906 / 0.8 3 2 0
4 Phosphofructokinase 1 Cytosolic 5211 669 1  1sl - 0.888 1  - 0 1 1
5 Aldolase A Cytosolic 226 668 0  - 0  - 3 0 0
6 Triosephosphate 
Isomerase
Cytosolic 7167 911 0  - 3  3sl - 0.771 / 0.806 / 
0.904
0 1 0
7 Gluceraldehyde 3 
Phosphate Dehydrogenase
Cytosolic 26330 718 13 10sl - 0.968 / 0.98 / 1.0 / 
1.0 / 0.974 / 0.931 / 0.935 
/ 0.918 / 0.722 / 0.891
4  3sl - 0.864 / 0.816 / 
0.76
4 0 1
8 Phosphoglyrate Kinase Cytosolic 5232 601 2 1sl - 0.86 5  3sl - 0.76 / 0.769 / 0.791 3 1 0
9 Phosphoglyrate Mutase Cytosolic 5224 799 1  - 3 3sl - 0.795 / 0.807 / 
0.869
2 0 0
10 Enolase Cytosolic 2027 612 4 4sl - 0.934 / 0.968 / 0.926 
/ 0.917
4  4sl - 0.796 / 0.793 / 
0.77 / 0.786 
4 2 0
11 Pyruvate Kinase Cytosolic 5313 648 3  2sl - 0.846 / 0.875 2  - 2 0 0
12 Lactate Dehydrogenase Cytosolic 3939 824 9 9sl - 0.909 / 0.97 / 1.0 / 
1.0 / 0.976 / 0.888 / 0.894 
/ .0911 / 0.817
2 2sl - 0.842 / 0.887 1 0 1
Krebs Cycle
13 Pyruvate Dehydrogenase 
(lipoamide) Alpha 1
MM 5160 777 4 3sl - 0.848 / 0.932 / 1.0 1  1sl - 0.847 1 1 2
14 Aconitase MM 48 663 0  - 3  2sl - 0.81 / 0.872 0 1 0
15 Isocitrate Dehydrogenase MM 3420 673 2  - 1  - 1 2 0
16 Oxoglutarate 
(alpha-ketoglutarate) 
Dehydrogenase
MM 4967 601 11 11sl - 0.854 / 1.0 / 1.0 / 
0.945 / 0.962 / 0.88 / 0.9 / 
0.926 / 0.921 / 0.892 / 
0.908
2  2sl - 0.774 / 0.705 0 1 10
17 Succinyl-CoA Synthetase 
Subunit Alpha
MM 8802 602 0  - 2  1sl - 0.956 1 0 0
18 Succinate Dehydrogenase 
C
MM 6391 614 5 4sl - 0.906 / 0.922 / 0.926 
/ 0.9
0  - 1 2 1
19 SDHA Succinate 
Dehydrogenase A
MM 6389 611 1  1sl - 0.844 2 2sl - 0.771 / 0.802 1 1 0
20 Succinate Dehydrogenase 
D
MM 6392 650 0  - 4 4sl - 0.831 / 0.877 / 
0.808 / 0.752
2 0 0
21 Fumarate Hydratase MM 2271 601 2 2sl - 0.879 / 0.908 0  - 2 0 1
22 Malate Dehydrogenase MM 4190 1141 0  - 5 5sl - 0.854 / 0.75 / 
0.799 / 0.803 / 0.809
3 1 2
Respiratory Chain
23 NDUFV3 flavoprotein 
NADH dehydrogenase
Complex I 
(MMI)
4731 670 2 2sl - 0.976 / 0.998 2  1sl - 0.799 3 0 2
24 NDUFV1 flavoprotein 
NADH dehydrogenase
Complex I 
(MMI)
4723 754 4 2sl - 0.941 / 0.983 3  2sl - 0.894 / 0.814 3 2 5
25 NDUFV2 flavoprotein 
NADH dehydrogenase
Complex I 
(MMI)
4729 668 4 2sl - 0.918 / 0.926 2  2sl - 0.802 / 0.804 3 0 1
SDHA  flavoprotein 
succinate dehydrogenase
Complex II 
(MMI)
6389 611 1  1sl - 0.844 2 2sl - 0.771 / 0.802 1 1 0
26 GPD1 (flavoprotein) 
glycerol 3-phosphate 
dehydrogenase (soluble)
External MMI 2819 611 1  1sl - 0.758 2  1sl - 0.761 1 0 2
27 GPD2 (flavoprotein) 
glycerol 3-phosphate 
dehydrogenase 
(mitochondrial)
External MMI 2820 912 4 3sl - 0.888 / 0.834 / 0.906 3  3sl - 0.725 / 0.762 / 
0.936
2 3 2
28 CYBA cytochrome b-245, 
alpha polypeptide
Complex III 
(MMI)
1535 662 2 2sl - 0.992 / 0.908 2 1sl - 0.779 2 0 2
29 UCRC ubiquinol-
cytochrome c reductase 
complex
Complex III 
(MMI)
29796 630 1  1sl - 0.888 1  1sl - 0.903 2 0 0
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Table 1. Continuation 
30 COX4I1 - cytochrome a / 
a3 subunit IV isoform 1
Complex IV 
(MMI)
1327 786 1 1sl - 0.921 1  1sl - 0.793 4 1 0
31 SLC25A31 solute carrier 
family 25, adenine 
nucleotide translocator 
member 31
MMI 83447 1049 9 6sl - 0.959 / 0.935 / 0.911 
/ 0.917 / 0.914 / 0.895
5 3sl - 0.765 / 0.762 / 
0.762
3 0 9
32 SLC25A6  solute carrier 
family 25, adenine 
nucleotide translocator 
member 6
MMI 293 772 4 3sl - 0.825 / 0.88 / 0.727 3 2sl - 0.898 / 0.828 0 3 2
33 SLC 25A4 solute carrier 
family 25, adenine 
nucleotide translocator 
member 4
MMI 291 740 0  - 2  1sl - 0.881 4 1 0
34 GPD1 glycerol 
3-phosphate 
dehydrogenase 1 (soluble)
Cytosolic 2819 611 1  1sl - 0.758 2  1sl - 0.761 1 0 2
35 MDH1 malate 
dehydrogenase 1
MMI (LMA) 4190 1141 0  - 5 5sl - 0.854 / 0.75 / 
0.799 / 0.803 / 0.809
6 1 2
36 GOT2 mitochondrial 
aspartate aminotransferase 2
MMI (LMA) 2806 734 7 5sl - 0.968 / 0.949 / 0.993 
/ 0.911 / 0.896
4 2sl - 0.804 / 0.769 1 2 4
37 GOT1 aspartate 
transferase 2
Cytosolic 2805 736 2  1sl - 0.885 1  1sl - 0.818 3 1 0
38 CS citrate synthase MMI 1431 753 5  2sl - 0.886 / 0.823 6 5sl - 0.872 / 0.823 / 
0.847 / 0.971 / 0.888
2 2 6
39 ACLY citrate lyase Cytosolic 47 749 0  - 0  - 1 0 2
40 UCP1 protein uncoupling 
1 
MMI (MBF) 7350 726 2  2sl - 0.911 / 0.881 5  4sl - 0.804 / 0.804 / 
0.76 / 0.905
4 2 3
41  UCP2 protein uncoupling 
2
rather than 
MBF
7351 1065 4  1sl - 0.901 4 3sl - 0.871 / 0.81 / 
0.886
1 0 8
42 UCP3 protein uncoupling 
3
rather than 
MBF
7352 1137 3  3sl - 0.831 / 0.823 / 
0.723
6 5sl - 0.874 / 0.804 / 
0.88 / 0.874 / 0.791 
7 3 1
43 UCP4 protein uncoupling 
4
rather than 
MBF
9481 602 1 1sl - 0.876 4 3sl - 0.862 / 0.845 / 
0.8
2 0 1
44 UCP5 protein uncoupling 
5
rather than 
MBF
9016 1183 3  3sl - 0.934 / 0.91 / 0.918 4  3sl - 0.778 / 0.809 / 
0.82
6 3 2
Glycogenolysis
45 Glycogen phosphorylase Cytosolic 5834 964 6  3sl - 0.925 / 0.918 / 
0.915
2  2sl - 0.809 / 0.818 2 0 0
46 Phosphoglucomutase Cytosolic 5239 1074 3 2sl - 0.961 / 0.93 2  1sl - 0.798 3 1 0
47 Glucose - 6 - Phosphate 
Translocase
Cytosolic 2542 601 1  1sl - 0.743 2  1sl - 0.83 2 0 0
48 Glucose - 6 - Phosphatase Cytosolic 57818 744 2  1sl - 0.878 1  - 1 1 0
β-Oxidation 
49 Acyl CoA Synthetase 
(ACSL 6)
Cytosolic 23305 775 2 2sl - 0.937 / 0.914 4 3sl - 0.862 / 0.91 / 
0.729
1 1 0
50 Acyl CoA Synthetase 
(ACSL 1)
Cytosolic 2180 601 1  - 1  1sl - 0.799 0 1 0
51 Carnitine Acyl Transferase Cytosolic / 
MM
1384 601 1  1sl - 0.723 2  1sl - 0.816 1 2 3
52 Acyl CoA Dehydrogenase MM 28976 803 13 11sl - 0.86 / 0.994 / 1.0 / 
1.0 / 1.0 / 0.985 / 0.935 / 
0.912 / 0.935 / 0.892 / 0.89
0  - 1 0 0
53 Enoyl CoA Hydratase MM 1891 832 7  5sl - 0.844 / 0.902 / 
0.922 / 0.893 / 0.744
1 1sl - 0.832 1 2 0
54 β Hydroxyacyl CoA 
Dehydrogenase
MM 3030 601 3 2sl - 0.98 / 0.968 3  1sl - 0.773 3 0 0
55 Thiolase 1 MM 38 679 6 5sl - 0.988 / 0.927 / 0.837 
/ 0.892 / 0.924
3 3sl - 0.808 / 0.775 / 
0.706
2 2 0
56 Thiolase 2 MM 39 733 3 3sl - 0.985 / 0.9 / 0.843 1  - 2 1 0
NCBI Gene identification number (ID); Mitochondrial brown fat (MBF); Cis-element sites (sl); mitochondrial membrane (MM); number of recognized sites (Nº).
nº
metabolic pathway 
enzyme
Cell 
localization
nCBI  
gene ID
 Initial screening by GenomATIX software
Second screening – filtering for 
T3R-b cis specific sites
Promoter 
size (bp)
Total nº 
of CReB 
cis sites
CReB (cAmP) score,  
p < 0.01
Total nº 
of RXRF 
cis sites 
RXRF (T3R-b) score, 
p < 0.01
Total nº 
PRomo 
software
Total nº 
AlIBABA2 
software
Total nº 
TeSS 
software
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Figure 1. Schematic representation of the interplay between fuel oxidation routes and thermogenesis. 1,5-lipid β-oxidation, 2-glycolysis, 3-glycogenoly-
sis, 4-proteolysis, 6-Krebs cycle, 7-respiratory chain, 8-oxidative phosphorylation and 9-uncoupling protein-meditated proton leak are potentially regu-
lated by T3 on promoting heat generation. * Glycogenic amino acids.
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Glucose phosphate isomerase (GPI, Gene ID: 
2821) is located on 19q13.1 and belongs to the GPI 
family, which members encode multifunctional phos-
phoglucose isomerase proteins involved in energy pa-
thways. We can expect that T3R/CREB regulation of 
GPI might increase glucose oxidation, thus generating 
more heat. In fact, GPI works as a dimeric enzyme 
that catalyzes the reversible isomerization of glucose-
6-phosphate and fructose-6-phosphate, so in the cyto-
plasm, the gene product is involved in glycolysis and 
gluconeogenesis (27). Interestingly, GPI seems to work 
outside the cell as a neurotrophic factor for spinal and 
sensory neurons. Mild defects in this gene cause nons-
pherocytic hemolytic anemia, while its severe enzyma-
tic deficiency can be associated with hydrops fetalis and 
immediate neonatal death associated with neurological 
impairment (28,29). GPI is differentially induced by a 
hypoxic environment as a transient adaptative response 
(30), as well as related to regulating cell proliferation, 
whereas its overexpression may increase in vitro neo-
plastic transformation (31).
Succinate dehydrogenase complex subunit C 
(SDHC, Gene ID: 6391) and succinate dehydrogenase 
complex subunit A (SDHA, Gene ID: 6389) have their 
genes located on 1q23.3 and 5p15, respectively. Each 
gene encodes one of four nuclear-encoded subunits that 
comprise succinate dehydrogenase, also known as the 
mitochondrial complex II, where other subunits of the 
complex anchor, thus forming the major catalytic core 
of succinate-ubiquinone oxidoreductase, placed in the 
inner mitochondrial membrane. In addition to partici-
pating in the aerobic respiratory chain of mitochondria, 
it is also a key enzyme complex of the tricarboxylic acid 
cycle (32). SDHC mutations have been associated with 
paragangliomas (33). Since alternatively spliced trans-
cript variants of these genes have been described, we may 
also speculate if T3R/CREB would contribute to one of 
these transcriptional fates, especially if variations in basal 
metabolic rate and in climate are taken into account. 
NADH dehydrogenase (ubiquinone) flavoprotein 1, 
also termed as NDUFV1 gene (Gene ID: 4723) encodes 
the 51-kD subunit of complex I (NADH: ubiquinone 
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oxidoreductase) of the mitochondrial respiratory chain 
and it is located on 11q13. Microarray analysis reveals 
that NDUFV1 is one of the six downregulated genes 
(among 297 genes) when obese and diabetic patients 
are fed with high fat diet (34). Interestingly each one of 
the six genes is known to be crucial for oxidative phos-
phorylation in the skeletal muscle; all of them work on 
regulation steps quite close to the terminal generation 
of ATP store. Thus, it is not surprising that T3R/CREB 
could transcriptionally modulate this metabolic route.
Cytochrome c oxidase (COX4I1, Gene ID: 1327) 
encodes the nuclear-encoded subunit IV isoform 1 − 
the terminal enzyme of the mitochondrial respiratory 
chain. It is part of a multi-subunit enzyme complex that 
couples the transfer of electrons from cytochrome c to 
molecular oxygen and contributes to a proton electro-
chemical gradient across the inner mitochondrial mem-
brane. The whole complex consists of 13 mitochondrial- 
and nuclear-encoded subunits, being COX4I1 located 
on 16q22-qter. In fact, this gene is genomically placed 
at the 3’ of the NOC4 (neighbor of COX4I1) gene 
in a head-to-head orientation, and curiously shares the 
promoter with it. Thus, it could be hypothesized that 
both genes are under T3R/CREB genome regulation 
as well as other mitochondrial enzymes pointed out in 
our in silico screening. Therefore, we suggest that this 
group of oxidation enzymes is potentially influenced 
by thyroid status, orchestrating the tone of metabolism 
either by the increase of thermodynamic chemical ener-
gy or by the increase of proton leak – a thermogenin 
(UCP) regulating role. Indeed, manipulating COX4I1 
expression on cytochrome c oxidase activity, terminal 
ATP production, oxygen consumption, and reactive 
oxygen species generation indicates that this subunit 
switch is a homeostatic response which optimizes the 
efficiency of respiration at different oxygen concentra-
tions, especially during temporary muscle hypoxia (35).
Another T3R/CREB possibly regulated enzyme is 
the mitochondrial uncoupling protein 5 (UCP5), which 
is a member of the larger family of mitochondrial anion 
carrier proteins (MACP) (36). The UCP5 gene, also 
termed SLC25A14 − a brain mitochondrial solute car-
rier family 25, member 14 (Gene ID: 9016) is located 
in Xq24. As other UCPs, it deviates oxidative phos-
phorylation from ATP synthesis with energy released 
as heat, also referred to as the mitochondrial proton 
leak. Moreover, UCPs facilitate the transfer of anions 
from the inner to the outer mitochondrial membrane 
and the return transfer of protons from the outer to the 
inner mitochondrial membrane, therefore altering pH 
gradient. The regulatory role of T3 on temperature ac-
climation has been postulated based on the observation 
of increased UCP3 expression in the skeletal muscle of 
rats kept over 8 weeks up to 8ºC, and that UCP3 ex-
pression is decreased in rats acclimated to 30ºC. Simi-
lar findings were verified in hyperthyroid rats compared 
with euthyroid controls (37).
Phosphoglucomutase 5 (PGM5, Gene ID: 5239) 
is a phosphotransferase enzyme involved in the inter-
conversion of glucose-1-phosphate and glucose-6-
phosphate, which has its gene located on 9q13 (38). 
Its activity is essential in the formation of carbohydra-
tes from glucose-6-phosphate and in the formation of 
glucose-6-phosphate from galactose and glycogen. In 
fact, it plays a key role in the control of the metabolism 
towards glycolysis and gluconeogenesis, directing the 
biochemical fate according to the availability of energy 
stored as ATP (39,40). 
In addition, the enzymes involved in lipid metabo-
lism -acetyl-Coenzyme A acetyltransferase 1 (or aceto-
acetyl Coenzyme A thiolase 1, ACAT1, Gene ID: 38) 
and acetyl-Coenzyme A acetyltransferase 2 (or aceto-
acetyl Coenzyme A thiolase 2, ACAT2 Gene ID: 39) 
were also pulled through the screening. They have their 
genes located on 11q22.3-q23.1 and 6q25.3, respec-
tively. The first encodes a mitochondrial enzyme that 
catalyzes the reversible formation of acetoacetyl-CoA 
from two molecules of acetyl-CoA, whereas the second 
gene encodes the cytosolic enzyme (thiolase 2). It has 
been suggested that ACAT reflects the metabolic status 
of the cell by the availability of acetyl molecules likely 
involved in insulin-mediated regulation (41). As des-
cribed for cytochrome P450 expression (42), we could 
suggest that these genes are similarly involved in the T3 
regulation of metabolism, even though further in vitro 
evidence is needed to support our initial insight on the 
T3R/CREB regulatory-participation hypothesis.
In accordance to our in silico findings, other in vitro 
evidence has indicated that T3-binding alters the con-
formation of the thyroid hormone receptor in such a 
way as to release the corepressor complex (inhibitory) 
and engage a coactivator complex that comprises multi-
ple histone acetyltransferases, including a steroid recep-
tor family coactivator, a p300/CREB-binding protein-
associated factor (PCAF), and a CREB binding protein 
(CBP) (2). Taken all together, we were able to assem-
ble this mechanism of partnership as illustrated in figu-
re 2. We also warn that cis-elements for T3R and CREB 
on regulatory genomic sequences can still be located 
T3 and cAMP regulatory role on thermometabolic genes
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Figure 2. Assembly mechanism of T3R-CREB gene expression regulation of oxidative enzymes involved in heat generating metabolism.
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a further 1.2Kb upstream of the potential promoter, 
even though the GENOMATIX program used in our 
study predicts the best sequence based on the conser-
vation between orthologs, termed as golden promoter. 
Furthermore, all nucleotide sequences analyzed can be 
provided when requested to the authors. 
In summary, our study identifies more enzymes in 
the complex spectrum of T3 genomic regulation over 
the existing ones. The abundance of functional T3-regu-
lated promoters throughout all the metabolic pathways, 
either alone or with cAMP co-regulation, suggests that 
the contribution of the thyroid hormone to phenotypic 
thermogenesis variation and acclimation is likely to be 
appreciable. This in silico prediction is underscored by 
the additional impact of either the overt or subclinical, 
hyper- or hypothyroidism condition (43-45) on gene 
expression variation, related to thermogenesis. Therefo-
re, this prediction sheds light on how thyroid hormone 
may influence the basal metabolic tune. It is particularly 
owing to such screening, and perhaps to certain associa-
ted roles (T3R/CREB) found in this work, that efforts 
are constantly being made, despite the well grounded 
hypothesis of the major T3-control of UCP expression, 
to validate in vitro, as yet unknown or unconfirmed 
joint roles in regulation, as the oxidative enzymes invol-
ved in heat generating metabolism. 
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